Barinthus Biotherapeutics (BRNS) Other financing activities (2020 - 2021)
Barinthus Biotherapeutics (BRNS) reported Other financing activities of $1.9 million for Q4 2021, up 4951.35% on a YoY basis from $37000.0 in Q4 2020, and up 582.12% quarter-over-quarter from $274000.0 in Q2 2021.
Barinthus Biotherapeutics (BRNS) Other financing activities (2020 - 2021) Analysis & Trends
Barinthus Biotherapeutics has reported Other financing activities for 2 years, with the latest figure at $1.9 million in Q4 2021.
- For the quarter ending Q4 2021, Other financing activities rose 4951.35% year-over-year to $1.9 million; the trailing twelve-month figure through Dec 2021 stood at $2.2 million (changed N/A YoY), and the FY2021 full-year result was $2.2 million, up 3698.25% from the prior year.
- Other financing activities for Q4 2021 stood at $1.9 million, up from $274000.0 in the prior quarter.
- The five-year high for Other financing activities was $1.9 million in Q4 2021, with the low at $22000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 1.87 Mn |
| Dec 31, 2021 | 1.87 Mn |
| Jun 30, 2021 | 274,000.00 |
| Jun 30, 2021 | 274,000.00 |
| Mar 31, 2021 | 22,000.00 |
| Mar 31, 2021 | 22,000.00 |
| Dec 31, 2020 | 37,000.00 |
| Dec 31, 2020 | 37,000.00 |